Guidelines for the use and management of long-acting injectable antipsychotics in serious mental ill...
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Long-acting injectable (LAI) formulations are not widely used in routine practice even though they offer advantages in terms of relapse prevention. As part of a process to improve the quality of care, the French Association for Biological Psychiatry and Neuropsychopharmacology (AFPBN) elaborated guidelines for the use and management of antipsychoti...
Alternative Titles
Full title
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3898013
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3898013
Other Identifiers
ISSN
1471-244X
E-ISSN
1471-244X
DOI
10.1186/1471-244X-13-340
